Literature DB >> 21509772

Late age at first full term birth is strongly associated with lobular breast cancer.

Polly A Newcomb1, Amy Trentham-Dietz, John M Hampton, Kathleen M Egan, Linda Titus-Ernstoff, Shaneda Warren Andersen, E Robert Greenberg, Walter C Willett.   

Abstract

BACKGROUND: Late age at first full-term birth and nulliparity are known to increase breast cancer risk. The frequency of these risk factors has increased in recent decades.
METHODS: The purpose of this population-based case-control study was to examine associations between parity, age at first birth (AFB), and specific histological subtypes of breast cancer. Women with breast cancer were identified from cancer registries in Wisconsin, Massachusetts, and New Hampshire. Control subjects were randomly selected from population lists. Interviews collected information on reproductive histories and other risk factors. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) of ductal, lobular, and mixed ductal-lobular breast cancer diagnosis in association with AFB and nulliparity.
RESULTS: AFB ≥30 years was associated with a 2.4-fold increase in risk of lobular breast cancer compared with AFB <20 years (OR, 2.4; 95% CI, 1.9-2.9). The association was less pronounced for ductal breast cancer (OR, 1.3; 95% CI, 1.2-1.4). Nulliparity was associated with increased risk for all breast cancer subtypes, compared with women with AFB <20 years, but the association was stronger for lobular (OR, 1.7; 95% CI, 1.3-2.2) than for ductal (OR, 1.2; 95% CI, 1.1-1.3) subtypes (P = .004). The adverse effects of later AFB was stronger with obesity (P = .03) in lobular, but not ductal, breast cancer.
CONCLUSIONS: Stronger associations observed for late AFB and nulliparity suggest that these factors preferentially stimulate growth of lobular breast carcinomas. Recent temporal changes in reproductive patterns and rates of obesity may impact the histological presentation of breast cancer.
Copyright © 2010 American Cancer Society.

Entities:  

Mesh:

Year:  2010        PMID: 21509772      PMCID: PMC3117094          DOI: 10.1002/cncr.25728

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  67 in total

1.  Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.

Authors:  Amanda I Phipps; Christopher I Li; Karla Kerlikowske; William E Barlow; Diana S M Buist
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

2.  Vital signs: state-specific obesity prevalence among adults --- United States, 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-08-06       Impact factor: 17.586

3.  Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years.

Authors:  Christopher I Li; Roger E Moe; Janet R Daling
Journal:  Arch Intern Med       Date:  2003-10-13

4.  Oral contraceptive use and risk of breast cancer by histologic type.

Authors:  Laura M Newcomer; Polly A Newcomb; Amy Trentham-Dietz; Matthew P Longnecker; E Robert Greenberg
Journal:  Int J Cancer       Date:  2003-10-10       Impact factor: 7.396

5.  The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004.

Authors:  Christie R Eheman; Kate M Shaw; Aliza Blythe Ryerson; Jacqueline W Miller; Umed A Ajani; Mary C White
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05-19       Impact factor: 4.254

6.  Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States).

Authors:  Laura M Newcomer; Polly A Newcomb; John D Potter; Yutaka Yasui; Amy Trentham-Dietz; Barry E Storer; Matthew P Longnecker; John A Baron; Janet R Daling
Journal:  Cancer Causes Control       Date:  2003-04       Impact factor: 2.506

7.  Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.

Authors:  T J Key; P N Appleby; G K Reeves; A Roddam; J F Dorgan; C Longcope; F Z Stanczyk; H E Stephenson; R T Falk; R Miller; A Schatzkin; D S Allen; I S Fentiman; T J Key; D Y Wang; M Dowsett; H V Thomas; S E Hankinson; P Toniolo; A Akhmedkhanov; K Koenig; R E Shore; A Zeleniuch-Jacquotte; F Berrino; P Muti; A Micheli; V Krogh; S Sieri; V Pala; E Venturelli; G Secreto; E Barrett-Connor; G A Laughlin; M Kabuto; S Akiba; R G Stevens; K Neriishi; C E Land; J A Cauley; L H Kuller; S R Cummings; K J Helzlsouer; A J Alberg; T L Bush; G W Comstock; G B Gordon; S R Miller; C Longcope
Journal:  J Natl Cancer Inst       Date:  2003-08-20       Impact factor: 13.506

8.  Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.

Authors:  Christopher I Li; Kathleen E Malone; Peggy L Porter; Noel S Weiss; Mei-Tzu C Tang; Kara L Cushing-Haugen; Janet R Daling
Journal:  JAMA       Date:  2003-06-25       Impact factor: 56.272

9.  Trends in incidence rates of invasive lobular and ductal breast carcinoma.

Authors:  Christopher I Li; Benjamin O Anderson; Janet R Daling; Roger E Moe
Journal:  JAMA       Date:  2003-03-19       Impact factor: 56.272

10.  Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age.

Authors:  Christopher I Li; Kathleen E Malone; Peggy L Porter; Noel S Weiss; Mei-Tzu C Tang; Janet R Daling
Journal:  Int J Cancer       Date:  2003-11-20       Impact factor: 7.396

View more
  18 in total

1.  Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers.

Authors:  Brian S Finkelman; Wendy S Rubinstein; Sue Friedman; Tara M Friebel; Shera Dubitsky; Niecee Singer Schonberger; Rochelle Shoretz; Christian F Singer; Joanne L Blum; Nadine Tung; Olufunmilayo I Olopade; Jeffrey N Weitzel; Henry T Lynch; Carrie Snyder; Judy E Garber; Joellen Schildkraut; Mary B Daly; Claudine Isaacs; Gabrielle Pichert; Susan L Neuhausen; Fergus J Couch; Laura van't Veer; Rosalind Eeles; Elizabeth Bancroft; D Gareth Evans; Patricia A Ganz; Gail E Tomlinson; Steven A Narod; Ellen Matloff; Susan Domchek; Timothy R Rebbeck
Journal:  J Clin Oncol       Date:  2012-03-19       Impact factor: 44.544

2.  Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis.

Authors:  S Warren Andersen; P A Newcomb; J M Hampton; L Titus-Ernstoff; K M Egan; A Trentham-Dietz
Journal:  Breast Cancer Res Treat       Date:  2011-07-19       Impact factor: 4.872

3.  Variation in Breast Cancer-Risk Factor Associations by Method of Detection: Results From a Series of Case-Control Studies.

Authors:  Brian L Sprague; Ronald E Gangnon; John M Hampton; Kathleen M Egan; Linda J Titus; Karla Kerlikowske; Patrick L Remington; Polly A Newcomb; Amy Trentham-Dietz
Journal:  Am J Epidemiol       Date:  2015-05-05       Impact factor: 4.897

4.  Mimicking pregnancy as a strategy for breast cancer prevention.

Authors:  Julia Santucci-Pereira; Christina George; David Armiss; Irma H Russo; Johana E Vanegas; Fathima Sheriff; Ricardo Lopez de Cicco; Yanrong Su; Patricia A Russo; Lucas T Bidinotto; Jose Russo
Journal:  Breast Cancer Manag       Date:  2013-07-01

5.  Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes.

Authors:  Polly A Newcomb; Ellen Kampman; Amy Trentham-Dietz; Kathleen M Egan; Linda J Titus; John A Baron; John M Hampton; Michael N Passarelli; Walter C Willett
Journal:  J Clin Oncol       Date:  2013-04-08       Impact factor: 44.544

6.  Cigarette Smoking Before and After Breast Cancer Diagnosis: Mortality From Breast Cancer and Smoking-Related Diseases.

Authors:  Michael N Passarelli; Polly A Newcomb; John M Hampton; Amy Trentham-Dietz; Linda J Titus; Kathleen M Egan; John A Baron; Walter C Willett
Journal:  J Clin Oncol       Date:  2016-01-25       Impact factor: 44.544

7.  Emerging Trends in Family History of Breast Cancer and Associated Risk.

Authors:  Oyewale O Shiyanbola; Robert F Arao; Diana L Miglioretti; Brian L Sprague; John M Hampton; Natasha K Stout; Karla Kerlikowske; Dejana Braithwaite; Diana S M Buist; Kathleen M Egan; Polly A Newcomb; Amy Trentham-Dietz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-10-06       Impact factor: 4.254

Review 8.  Reproductive history and breast cancer risk.

Authors:  Shunzo Kobayashi; Hiroshi Sugiura; Yoshiaki Ando; Norio Shiraki; Takeshi Yanagi; Hiroko Yamashita; Tatsuya Toyama
Journal:  Breast Cancer       Date:  2012-06-19       Impact factor: 4.239

Review 9.  Circulatory estrogen level protects against breast cancer in obese women.

Authors:  Zsuzsanna Suba
Journal:  Recent Pat Anticancer Drug Discov       Date:  2013-05       Impact factor: 4.169

10.  Do reproductive factors influence T, N, and M classes of ductal and lobular breast cancers? A nation-wide follow-up study.

Authors:  Seyed Mohsen Mousavi; Asta Försti; Kristina Sundquist; Kari Hemminki
Journal:  PLoS One       Date:  2013-05-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.